Aravis Ventures logo

Aravis Ventures

Europe, Zurich, Switzerland, Zürich

Description

Aravis Ventures is a private equity firm that invests in renewable energy and life sciences sector.

Investor Profile

Aravis Ventures has made 31 investments, with 1 in the past 12 months and 29% as lead.

Stage Focus

  • Series A (45%)
  • Series B (29%)
  • Series C (10%)
  • Series Unknown (10%)
  • Series E (3%)
  • Series D (3%)

Country Focus

  • Switzerland (42%)
  • United States (35%)
  • Singapore (10%)
  • The Netherlands (3%)
  • Denmark (3%)
  • Germany (3%)
  • Belgium (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Food And Beverage
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aravis Ventures frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 12
Tavistock Life Sciences
North America, Florida, United States, Windermere
Co-Investments: 3
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 11
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 5
Co-Investments: 4
VINCI CAPITAL
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 3
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4

What are some of recent deals done by Aravis Ventures?

Hedera-22

Liège, Liege, Belgium

R&D of innovative products based on the use of new natural molecules

Biotechnology
Series UnknownAug 14, 2024
Amount Raised: $2,204,875
Bird Rock Bio

La Jolla, California, United States

Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators.

BiotechnologyLife ScienceTherapeutics
Series BMar 27, 2014
Amount Raised: $15,000,000
Synaffix BV

Oss, Noord-Brabant, The Netherlands

Synaffix BV creates an antibody conjugation technology platform to aid in the treatment of cancer and other disorders.

BiotechnologyHealth CareTherapeutics
Series AFeb 18, 2014
Bellerophon Therapeutics

Warren, New Jersey, United States

Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.

BiotechnologyHealth CareMedical
Series ADec 26, 2013
Amount Raised: $80,000,000
Telormedix

Bioggio, Ticino, Switzerland

Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series BDec 2, 2013
Amount Raised: $8,340,532
Telormedix

Bioggio, Ticino, Switzerland

Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series BJan 25, 2012
Amount Raised: $6,464,319
Synosia Therapeutics

Basel, Basel-Stadt, Switzerland

Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.

BiotechnologyMedicalTherapeutics
Series COct 12, 2010
Amount Raised: $30,000,000
MerLion Pharma

Singapore, Central Region, Singapore

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

BiotechnologyPharmaceutical
Series COct 11, 2010
Amount Raised: $7,000,000
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BDec 11, 2009
Amount Raised: $15,518,703
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BOct 22, 2009
Amount Raised: $27,828,853